Abstract
Summary
We present the case of a 28-year-old female Rett syndrome patient with low bone mass and a recent fracture who was successfully treated with teriparatide. Bone mineral density and microarchitecture substantially improved after treatment. Rett syndrome (RTT), an X-linked progressive neuro-developmental disorder caused by mutations in the methyl-CpG-binding 2 (MECP2) gene, has been consistently associated with low bone mass. Consequently, patients with RTT are at increased risk of skeletal fractures. Teriparatide is a bone-forming agent for the treatment of osteoporosis that has demonstrated its effectiveness in increasing bone strength and reducing the risk of fractures in postmenopausal women, but, recently, its positive action has also been reported in premenopausal women. We present the case of a 28-year-old female RTT patient with low bone mass and a recent fracture who was successfully treated with teriparatide. Both bone mass measured by DXA and microarchitecture assessed by high resolution peripheral computed tomography (HR pQCT) were substantially improved after treatment.
Abbreviations
- RTT:
-
Rett syndrome
- MECP2:
-
methyl-CpG-binding 2
- HR-pQCT:
-
high resolution peripheral computarized tomography
References
Lyst MJ, Bird A (2015) Rett syndrome: a complex disorder with simple roots. Nat Rev Genet 16:261–275
Laurvick CL, de Klerk N, Bower C, Christodoulou J, Ravine D, Ellaway C, Williamson S, Leonard H (2006) Rett syndrome in Australia: a review of the epidemiology. J Pediatr 148:347–352
Weaving LS, Ellaway CJ, Gécz J, Christodoulou J (2005) Rett syndrome: clinical review and genetic update. J Med Genet 42:1–7
Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ (1997) Osteopenia in Rett syndrome. J Pediatr 131:771–774
Downs J, Bebbington A, Woodhead H, Jacoby P, Jian L, Jefferson A, Leonard H (2008) Early determinants of fractures in Rett syndrome. Pediatrics 121:540–546
Jefferson AL, Woodhead HJ, Fyfe S, Briody J, Bebbington A, Strauss BJ, Jacoby P, Leonard H (2011) Bone mineral content and density in Rett syndrome and their contributing factors. Pediatr Res 69:293–298
Motil KJ, Ellis KJ, Barrish JO, Caeg E, Glaze DG (2008) Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res 64:435–439
Budden SS, Gunness ME (2001) Bone histomorphometry in three females with Rett syndrome. Brain Dev 23:S133–S137
Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726–1733
Blue ME, Boskey AL, Doty SB, Fedarko NS, Hossain MA, Shapiro JR (2015) Osteoblast function and bone histomorphometry in a murine model of Rett syndrome. Bone 76:23–30
Kamal B, Russell D, Payne A, Constante D, Tanner KE, Isaksson H, Mathavan N, Cobb SR (2015) Biomechanical properties of bone in a mouse model of Rett syndrome. Bone 71:106–114
Jefferson A, Leonard H, Siafarikas A, Woodhead H, Fyfe S, Ward LM et al (2016) Clinical guidelines for management of bone health in Rett syndrome based on expert consensus and available evidence. PLoS ONE 11:e0146824
Lotan M, Reves-Siesel R, Eliav-Shalev RS, Merrick J (2013) Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis. Osteoporos Int 24:3059–3063
Caffarelli C. Teriparatide in the treatment of recurrent fractures in a Rett patient. Clin Cases Min Bone Metab. 2015.
Girotra M, Rubin MR, Bilezikian JP (2006) The use of parathyroid hormone in the treatment of osteoporosis. Rev Endocr Metab Disord 7:113–121
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster J-Y, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. Obstet Gynecol Surv 56:623–624
Cohen A, Stein EM, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S, McMahon DJ, Nickolas TL, Müller R, Zwahlen A, Young P, Stubby J, Shane E (2013) Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study. J Clin Endocrinol Metab 98:1971–1981
Acknowledgments
The authors would like to thank the child and her family for allowing us to use the medical documentation and information that led to the present article.
We thank Susana Carballo for editing the English language of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Rights and permissions
About this article
Cite this article
Zanchetta, M.B., Scioscia, M.F. & Zanchetta, J.R. Bone microarchitecture in Rett syndrome and treatment with teriparatide: a case report. Osteoporos Int 27, 2873–2877 (2016). https://doi.org/10.1007/s00198-016-3586-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-016-3586-7